PlainPatent
USPTO 2015–2025 USPTO PatentsView US Corporation

Arcutis Biotherapeutics, Inc.

USPTO PatentsView assignee record - 24 granted patents across 4 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company
Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Arcutis ranks #12,352 of 49,997 tracked US assignees by granted-patent volume, with 24 patents across 4 technology areas.

#12,352
of 49,997 US assignees by volume
Top 14%
by Innovation Score (50.0/100)
19.7
avg claims per patent

USPTO PatentsView assignee plate

Corpus R12352 · US Corporation #12,352 · 24 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-SMALL 24 grants
  • UPPER-Q #12,352/49,997
  • PHOTO-FINISH Acalvio
  • CPC-NARROW A61K · 4 areas
  • INNOV-PAR 50.0/100
  • CLAIMS-RICH 19.7 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2021–2025 · 5y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Acalvio Technologies, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Arcutis’s 50.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Arcutis

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Arcutis's Innovation Score is 50.0/100 (top 14% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Arcutis?

Each dot is one of Arcutis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Arcutis’s own 19.7 claims/patent is ABOVE the 15.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Arcutis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 23.923.92424.1 51015202530 Granted patents (volume) Avg claims / patent Allway Tools, Inc. - 24, 9.5Allway ToolsAlphamicron Incorporated - 24, 25.38Alphamicron Incor…Amtab Manufacturing Corporation - 24, 7.29Amtab Manufacturi…Appvance Inc. - 24, 15.54AppvanceArrow International LLC - 24, 18.04Arrow Internation…Assia Chemical Industries Ltd. - 24, 12.96Assia Chemical In…Avigilon Patent Holding 1 Corporation - 24, 18.17Avigilon Patent H…Acalvio Technologies, Inc. - 24, 23.62AcalvioArcutis Biotherapeutics, Inc. - 24, 19.71Arcutis Biotherap…
Arcutis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Arcutis's grants concentrate

Arcutis Biotherapeutics, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2024 (11 grants) versus a trough of 1 in 2021. By volume, Arcutis sits between Allway Tools, Inc. and Acalvio Technologies, Inc..

Arcutis's three-year grant acceleration

Arcutis Biotherapeutics, Inc. shows 17 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Arcutis's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Arcutis holds 24 patents at rank #12,340, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Arcutis

By rank, the assignees closest to #12,340 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Arcutis's primary technology class.

Arcutis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

50 Top 14% higher than 86% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

051015 20212022202320242025 6
USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table
Arcutis Biotherapeutics, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2021 1 4.2%
2022 1 4.2%
2023 5 20.8%
2024 11 45.8%
2025partial year 6 25.0%

Which technologies does Arcutis Biotherapeutics, Inc. patent most?

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Arcutis Biotherapeutics, Inc.'s patent record in context - here's where to go next.

  • Arcutis Biotherapeutics, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #12,352 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Arcutis Biotherapeutics, Inc. against Allway Tools, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 50.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.